Shi P

ORCID: 0000-0002-6904-2802 · 6 papers in corpus
observational 2026
BMC women's health ·doi:10.1186/s12905-026-04725-3

BACKGROUND: Dysmenorrhea is a common gynecological condition with heterogeneous etiologies. Endometriosis is an important condition associated with dysmenorrhea, but the serum steroid and reproductive hormone profiles related to dysmenorrhe…

other 2024
Iranian biomedical journal ·doi:10.61186/ibj.4068

BACKGROUND: The 17beta-hydroxysteroid dehydrogenase type 1 (HSD17B) family has been implicated in the prognosis and treatment prediction of various malignancies; however, its association with bladder cancer (BLCA) remains unclear. This stud…

rct 2022
Frontiers in pharmacology ·doi:10.3389/fphar.2022.1027648

Background: Treatment with gonadotropin-releasing hormone (GnRH) antagonists is a powerful strategy to suppress gonadotropin activity in women with sex hormone-dependent disorders. Herein, we provide the safety, pharmacokinetics (PK), and p…

observational 2021
Cancer management and research ·doi:10.2147/cmar.s321173

PURPOSE: Minimally invasive surgery (MIS) is performed frequently in early-stage ovarian cancer patients, especially in ovarian clear cell carcinoma (OCCC). The aim of this study was to investigate whether primary laparoscopic surgery influ…

review 2018
OncoTargets and therapy ·doi:10.2147/ott.s159829

Ovarian cancer is the leading cause of female gynecological cancer mortality. Most patients with ovarian cancer are diagnosed with advanced stage because of lack of early symptoms, physical signs, and sensitive tumor biomarkers. The standar…

other 2015
Lancet (London, England) ·doi:10.1016/s0140-6736(15)61340-x

BACKGROUND: The Global Burden of Disease Study 2013 (GBD 2013) aims to bring together all available epidemiological data using a coherent measurement framework, standardised estimation methods, and transparent data sources to enable compari…